Heart Test Laboratories (NASDAQ:HSCS) Price Target Lowered to $14.00 at Ascendiant Capital Markets

Heart Test Laboratories (NASDAQ:HSCSGet Free Report) had its price target cut by analysts at Ascendiant Capital Markets from $15.00 to $14.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Ascendiant Capital Markets’ target price would indicate a potential upside of 359.02% from the stock’s previous close.

Separately, Maxim Group reaffirmed a “buy” rating and set a $12.00 price target on shares of Heart Test Laboratories in a report on Wednesday, December 18th.

View Our Latest Stock Report on Heart Test Laboratories

Heart Test Laboratories Trading Up 4.1 %

Shares of Heart Test Laboratories stock opened at $3.05 on Tuesday. The stock has a market capitalization of $2.99 million, a PE ratio of -0.39 and a beta of 2.77. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.72 and a quick ratio of 1.52. The company’s fifty day simple moving average is $3.44 and its 200-day simple moving average is $3.43. Heart Test Laboratories has a 1-year low of $2.36 and a 1-year high of $13.50.

Heart Test Laboratories (NASDAQ:HSCSGet Free Report) last posted its quarterly earnings data on Thursday, March 13th. The company reported ($2.57) EPS for the quarter, missing the consensus estimate of ($2.53) by ($0.04). As a group, equities analysts anticipate that Heart Test Laboratories will post -10.01 earnings per share for the current year.

Heart Test Laboratories Company Profile

(Get Free Report)

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.

See Also

Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.